11 Results for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Standards
|
|
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 2 |
Material Type: Standards
|
|
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 3 |
Material Type: Standards
|
|
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 4 |
Material Type: Standards
|
|
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 5 |
Material Type: Standards
|
|
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumabNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 6 |
Material Type: Standards
|
|
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 7 |
Material Type: Standards
|
|
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancerNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 8 |
Material Type: Standards
|
|
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 9 |
Material Type: Standards
|
|
Early and locally advanced breast cancer: diagnosis and managementNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 10 |
Material Type: Standards
|
|
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 11 |
Material Type: Standards
|
|
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyNICE Guidance, 2016Copyrights: © NICE 2016 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2016 (1)
- 2016 To 2016 (1)
- 2017 To 2017 (1)
- 2018 To 2019 (5)
- After 2019 (4)
-
More options
New Records
Subject
- Clinical Practice Guidelines (10)
- Cancer Therapies (10)
- Chemotherapy (9)
- Committees (8)
- Epidermal Growth Factor (7)
- Patients (6)
- Metastasis (6)
- Endocrine Therapy (5)
- Decision Making (5)
- Marketing (5)
- Drug Dosages (4)
- Surgery (4)
- Lymphatic System (4)
- Clinical Medicine (4)
- Neutropenia (3)
- Clinical Trials (3)
- Quality Of Life (3)
- Cyclin-Dependent Kinases (3)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||